- A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs. Abendschein, D.R., Baum, P.K., Verhallen, P., Eisenberg, P.R., Sullivan, M.E., Light, D.R. J. Pharmacol. Exp. Ther. (2001)